Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria R. Parkhurst
Induction of CD4+ Th1 Lymphocytes That Recognize Known and Novel Class II MHC Restricted Epitopes From the Melanoma Antigen Gp100 by Stimulation With Recombinant Protein
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Related publications
MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells From Melanoma Patients
PLoS ONE
Multidisciplinary
Major Histocompatibility Complex Class II DR-Restricted Memory CD4+ T Lymphocytes Recognize Conserved Immunodominant Epitopes of Anaplasma Marginale Major Surface Protein 1a
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Induction and Isolation of Tumor Antigen-Specific CD4+ T Lymphocytes Using Sorting Signal Directed MHC Class-Ii Expression
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Identification of a MHC Class II-Restricted Human Gp100 Epitope Using DR4-IE Transgenic Mice
Journal of Immunology
Allergy
Immunology
Melanosomal Targeting Sequences From Gp100 Are Essential for MHC Class II–Restricted Endogenous Epitope Presentation and Mobilization to Endosomal Compartments
Cancer Research
Cancer Research
Oncology
The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues
Journal of Immunology
Allergy
Immunology
MHC Class II-Transduced Tumor Cells Originating in the Immune-Privileged Eye Prime and Boost CD4+ T Lymphocytes That Cross-React With Primary and Metastatic Uveal Melanoma Cells
Cancer Research
Cancer Research
Oncology
Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells
Cancer immunology research
Cancer Research
Immunology
The CD8 Population in CD4-deficient Mice Is Heavily Contaminated With MHC Class II–restricted T Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
